Annual Review of Medicine

Papers
(The TQCC of Annual Review of Medicine is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Phage Therapy for Antibiotic-Resistant Bacterial Infections184
The Gut–Brain Axis165
mRNA Vaccines in the COVID-19 Pandemic and Beyond117
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment89
Hepatocellular Carcinoma Immunotherapy87
The Role of Exercise in Management of Mental Health Disorders: An Integrative Review80
Engineering IL-2 to Give New Life to T Cell Immunotherapy69
Hepcidin and Iron in Health and Disease66
The Gut Microbiome and Inflammatory Bowel Diseases58
Diagnosis and Treatment of Helicobacter pylori Infection55
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines54
COVID-19 and Diabetes51
New Therapeutics for Ulcerative Colitis51
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies49
Post-COVID-19 Condition45
Direct-to-Consumer Genetic Testing: Value and Risk44
Hematopoietic Stem Cell Transplantation for Autoimmune Disease43
Cardiovascular Effects of Particulate Air Pollution42
COVID-19: Inflammatory Profile41
COVID-19 Vaccines: Adenoviral Vectors41
COVID-19: Challenges of Viral Variants41
Therapeutics Targeting Mutant KRAS40
Synchronizing Brain Rhythms to Improve Cognition39
New Therapeutics for Hepatitis B: The Road to Cure38
Wearable Devices to Monitor and Reduce the Risk of Cardiovascular Disease: Evidence and Opportunities37
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression36
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches36
Aspirin in the Prevention of Colorectal Neoplasia36
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches34
Advances in Chronic Obstructive Pulmonary Disease33
Cytokine Storm Syndrome32
Clinical Perspectives on IgG4-Related Disease and Its Classification32
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone31
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy31
Toward Better Understanding and Management of CAR-T Cell–Associated Toxicity31
0.034718036651611